Regenxbio IncNASDAQ:RGNX
- LAST PRICE9.9200
- TODAY'S CHANGE (%)-0.2900 (-2.8404%)
- Bid / Lots9.8000/ 1
- Ask / Lots10.3000/ 4
- Open / Previous Close10.1900 / 10.2100
- Day Range
- 52 Week Range
- Volume749,278
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | RGNX |
|---|---|---|
| 09:32 ET | 6545 | 10.07 |
| 09:34 ET | 1378 | 9.95 |
| 09:36 ET | 1992 | 10.08 |
| 09:38 ET | 950 | 10.085 |
| 09:39 ET | 5400 | 10.05 |
| 09:41 ET | 1400 | 10.1 |
| 09:43 ET | 5802 | 10.0003 |
| 09:45 ET | 100 | 10 |
| 09:48 ET | 700 | 9.98 |
| 09:50 ET | 692 | 9.99 |
| 09:52 ET | 7225 | 9.995 |
| 09:54 ET | 900 | 9.99 |
| 09:56 ET | 200 | 9.985 |
| 09:57 ET | 6000 | 9.9697 |
| 09:59 ET | 2151 | 9.98 |
| 10:01 ET | 3500 | 9.97 |
| 10:03 ET | 1200 | 10.06 |
| 10:08 ET | 500 | 10.09 |
| 10:10 ET | 6110 | 10.14 |
| 10:12 ET | 1386 | 10.14 |
| 10:14 ET | 300 | 10.14 |
| 10:15 ET | 710 | 10.14 |
| 10:17 ET | 200 | 10.165 |
| 10:19 ET | 1573 | 10.205 |
| 10:21 ET | 400 | 10.22 |
| 10:24 ET | 3709 | 10.19 |
| 10:26 ET | 4627 | 10.13 |
| 10:28 ET | 284 | 10.15 |
| 10:30 ET | 3256 | 10.15 |
| 10:32 ET | 4779 | 10.245 |
| 10:33 ET | 564 | 10.224 |
| 10:35 ET | 600 | 10.25 |
| 10:37 ET | 100 | 10.25 |
| 10:42 ET | 5734 | 10.25 |
| 10:44 ET | 600 | 10.28 |
| 10:46 ET | 400 | 10.28 |
| 10:50 ET | 200 | 10.29 |
| 10:53 ET | 2413 | 10.26 |
| 11:02 ET | 391 | 10.23 |
| 11:04 ET | 2651 | 10.16 |
| 11:06 ET | 2700 | 10.17 |
| 11:08 ET | 102 | 10.16 |
| 11:09 ET | 902 | 10.05 |
| 11:11 ET | 900 | 10.07 |
| 11:13 ET | 2071 | 10.06 |
| 11:15 ET | 2870 | 10.07 |
| 11:18 ET | 600 | 10.08 |
| 11:20 ET | 800 | 10.105 |
| 11:24 ET | 1400 | 10.045 |
| 11:26 ET | 1493 | 10.03 |
| 11:27 ET | 100 | 10.01 |
| 11:29 ET | 4398 | 9.99 |
| 11:31 ET | 1084 | 9.995 |
| 11:36 ET | 905 | 10.03 |
| 11:38 ET | 1530 | 10.025 |
| 11:40 ET | 6861 | 10.05 |
| 11:44 ET | 799 | 10.0502 |
| 11:45 ET | 1500 | 10.09 |
| 11:51 ET | 2406 | 10.075 |
| 11:54 ET | 848 | 10.05 |
| 11:56 ET | 100 | 10.03 |
| 11:58 ET | 861 | 10.05 |
| 12:00 ET | 100 | 10.06 |
| 12:03 ET | 729 | 10.06 |
| 12:05 ET | 2400 | 10.035 |
| 12:07 ET | 400 | 10.02 |
| 12:09 ET | 3934 | 10.025 |
| 12:14 ET | 2454 | 10.04 |
| 12:16 ET | 450 | 10.0402 |
| 12:18 ET | 6837 | 10.065 |
| 12:20 ET | 352 | 10.04 |
| 12:21 ET | 1273 | 10.02 |
| 12:23 ET | 500 | 10.04 |
| 12:25 ET | 300 | 10.03 |
| 12:30 ET | 700 | 10.0536 |
| 12:32 ET | 1543 | 10.03 |
| 12:34 ET | 500 | 10.01 |
| 12:36 ET | 2660 | 10.02 |
| 12:38 ET | 1700 | 10 |
| 12:39 ET | 600 | 10.01 |
| 12:41 ET | 3617 | 10.06 |
| 12:43 ET | 500 | 10.04 |
| 12:45 ET | 212 | 10.03 |
| 12:48 ET | 5200 | 10.025 |
| 12:50 ET | 4342 | 10.02 |
| 12:52 ET | 3410 | 10.01 |
| 12:54 ET | 52051 | 9.99 |
| 12:56 ET | 1581 | 9.965 |
| 12:57 ET | 2900 | 10.02 |
| 12:59 ET | 500 | 10.03 |
| 01:01 ET | 300 | 10.02 |
| 01:03 ET | 1151 | 10.015 |
| 01:06 ET | 2567 | 9.99 |
| 01:08 ET | 1900 | 10.01 |
| 01:12 ET | 599 | 10.01 |
| 01:14 ET | 2000 | 10.03 |
| 01:15 ET | 219 | 10.01 |
| 01:17 ET | 438 | 10.01 |
| 01:19 ET | 900 | 10.02 |
| 01:21 ET | 800 | 10.03 |
| 01:24 ET | 200 | 10.05 |
| 01:26 ET | 100 | 10.046 |
| 01:28 ET | 800 | 10.035 |
| 01:30 ET | 200 | 10.03 |
| 01:32 ET | 5379 | 10.05 |
| 01:33 ET | 1100 | 10.0601 |
| 01:35 ET | 100 | 10.05 |
| 01:37 ET | 4105 | 10.0201 |
| 01:39 ET | 4761 | 10.02 |
| 01:42 ET | 1300 | 10.04 |
| 01:44 ET | 600 | 10.03 |
| 01:46 ET | 1070 | 10.02 |
| 01:48 ET | 200 | 10.03 |
| 01:50 ET | 200 | 10.04 |
| 01:51 ET | 608 | 10.045 |
| 01:53 ET | 2000 | 10.08 |
| 01:55 ET | 823 | 10.09 |
| 01:57 ET | 2085 | 10.06 |
| 02:00 ET | 250 | 10.06 |
| 02:02 ET | 100 | 10.05 |
| 02:04 ET | 355 | 10.05 |
| 02:06 ET | 1100 | 10.09 |
| 02:08 ET | 986 | 10.08 |
| 02:09 ET | 200 | 10.07 |
| 02:13 ET | 1482 | 10.09 |
| 02:15 ET | 300 | 10.09 |
| 02:18 ET | 400 | 10.08 |
| 02:22 ET | 1200 | 10.09 |
| 02:24 ET | 400 | 10.09 |
| 02:26 ET | 200 | 10.09 |
| 02:27 ET | 2300 | 10.11 |
| 02:29 ET | 599 | 10.06 |
| 02:31 ET | 10159 | 10.1 |
| 02:33 ET | 1800 | 10.11 |
| 02:36 ET | 796 | 10.1205 |
| 02:38 ET | 800 | 10.13 |
| 02:40 ET | 2300 | 10.17 |
| 02:44 ET | 2169 | 10.15 |
| 02:47 ET | 1400 | 10.15 |
| 02:49 ET | 807 | 10.185 |
| 02:51 ET | 800 | 10.15 |
| 02:54 ET | 200 | 10.12 |
| 02:56 ET | 3403 | 10.08 |
| 03:00 ET | 1900 | 10.08 |
| 03:02 ET | 100 | 10.08 |
| 03:03 ET | 1800 | 10.08 |
| 03:05 ET | 100 | 10.08 |
| 03:07 ET | 1001 | 10.08 |
| 03:09 ET | 999 | 10.09 |
| 03:12 ET | 1558 | 10.095 |
| 03:14 ET | 100 | 10.08 |
| 03:18 ET | 100 | 10.09 |
| 03:20 ET | 1313 | 10.075 |
| 03:21 ET | 600 | 10.05 |
| 03:25 ET | 3790 | 10.02 |
| 03:27 ET | 499 | 10.02 |
| 03:30 ET | 9648 | 9.96 |
| 03:32 ET | 3638 | 9.95 |
| 03:34 ET | 1737 | 9.96 |
| 03:36 ET | 9300 | 10.02 |
| 03:38 ET | 1699 | 10.01 |
| 03:39 ET | 1199 | 10.015 |
| 03:41 ET | 3014 | 10.005 |
| 03:43 ET | 1192 | 10.005 |
| 03:45 ET | 2818 | 9.99 |
| 03:48 ET | 7855 | 9.955 |
| 03:50 ET | 2997 | 9.92 |
| 03:52 ET | 7886 | 9.96 |
| 03:54 ET | 19083 | 9.96 |
| 03:56 ET | 11915 | 9.955 |
| 03:57 ET | 15338 | 9.96 |
| 03:59 ET | 133044 | 9.92 |
Sep 23, 2024
REGENXBIO to Participate in Chardan's 8th Annual Genetic Medicines Conference, from 4:05PM ET on Monday Sep 23, 2024 by Dow Jones
4:05PM ET on Monday Sep 23, 2024 by Dow Jones
Sep 17, 2024
DJ Regenxbio Names Chan Finance Chief as Vasista Departs, from 7:53AM ET on Tuesday Sep 17, 2024 by Dow Jones
7:53AM ET on Tuesday Sep 17, 2024 by Dow JonesREGENXBIO Appoints Mitchell Chan as Chief Financial Officer, from 7:05AM ET on Tuesday Sep 17, 2024 by Dow Jones
7:05AM ET on Tuesday Sep 17, 2024 by Dow Jones*DJ REGENXBIO Appoints Mitchell Chan As Chief Financial Officer >RGNX, from 7:05AM ET on Tuesday Sep 17, 2024 by Dow Jones
7:05AM ET on Tuesday Sep 17, 2024 by Dow Jones
Sep 4, 2024
DJ REGENXBIO Price Target Maintained With a $39.00/Share by HC Wainwright & Co., from 12:46PM ET on Wednesday Sep 04, 2024 by Dow Jones
12:46PM ET on Wednesday Sep 04, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Regenxbio Inc | 504.6M | -1.9x | --- |
Urogen Pharma Ltd | 525.6M | -3.8x | --- |
SAGE Therapeutics Inc | 424.9M | -0.9x | --- |
Alector Inc | 442.8M | -2.5x | --- |
Grail Inc | 411.4M | -0.1x | --- |
Y-mAbs Therapeutics Inc | 588.8M | -25.1x | --- |
Company Information
REGENXBIO Inc. is a clinical-stage biotechnology company seeking to improve lives through the curative potential of gene therapy. The Company has developed a pipeline of gene therapy programs using its proprietary adeno-associated virus (AAV) gene therapy delivery platform (NAV Technology Platform) to address genetic diseases. The Company is focused on its internal development pipeline in three areas: retinal, neuromuscular and neurodegenerative diseases. Its investigational AAV therapeutics include ABBV-RGX-314, RGX-202 and RGX-121. It is developing ABBV-RGX-314 in collaboration with AbbVie to treat large patient populations impacted by wet age-related macular degeneration, diabetic retinopathy (DR) and other chronic retinal diseases characterized by loss of vision. It is developing RGX-202 to treat Duchenne muscular dystrophy (Duchenne). The Company is developing RGX-121 to treat Mucopolysaccharidosis type II (MPS II), a progressive, neurodegenerative lysosomal storage disorder.
Contact Information
- Headquarters
- 9804 Medical Center DriveROCKVILLE, MD, United States 20850
- Phone
- 240-552-8181
- Fax
- 302-655-5049
Executives
- Chairman of the Board
- Kenneth Mills
- President, Chief Executive Officer, Director
- Curran Simpson
- Chief Financial Officer, Executive Vice President, Principal Accounting Officer
- Mitchell Chan
- Executive Vice President, Chief Scientific Officer
- Olivier Danos
- Executive Vice President, Chief Legal Officer
- Patrick Christmas
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $504.6M |
|---|---|
Revenue (TTM) | $89.0M |
Shares Outstanding | 49.4M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.21 |
EPS | $-5.27 |
Book Value | $7.08 |
P/E Ratio | -1.9x |
Price/Sales (TTM) | 5.7 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -279.37% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
